DemeRx - Crunchbase Company Profile & Funding

Q: Where is DemeRx's headquarters?

DemeRx is located in Destin, Florida, United States.

Q: When was the last funding round for DemeRx?

DemeRx closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

DemeRx

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About DemeRx

CB Rank

170249

DemeRx, Inc. develops treatment for drug addiction among patients coping with chronic pain.

Founded

obfuscation

Private

Venture - Series Unknown

Destin, Florida, United States

11-50

demerx.com/

Health Care

Health Diagnostics

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Deborah Mash: CEO and Founder
Vitaly Pirotsky: Strategic advisor and Chief business officer

Details

Operating Status

Active

Company Type

For Profit

Founders

Deborah Mash

About the Company

DemeRx develops treatment for drug addiction among patients coping with chronic pain. The company was incorporated in 2010 and is based in Destin, Florida.

Phone Number

(850) 650-1010

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

DMX-1001 (oral noribogaine)

An investigational oral therapy for alcohol use disorder aimed at addressing addiction by leveraging neuroplasticity.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - DemeRx	—	obfuscated obfuscation	—	Venture - Series Unknown